![]() Incidence and, where possible, etiologies were determined. Main Outcomes and Measures Infants with SCID and other diagnoses of T-cell lymphopenia were classified. Representatives from 10 states plus the Navajo Area Indian Health Service contributed data from 3 030 083 newborns screened with a TREC test. Infants born from the start of each participating program from January 2008 through the most recent evaluable date prior to July 2013 were included. Setting Representatives in states conducting SCID newborn screening were invited to submit their SCID screening algorithms, test performance data, and deidentified clinical and laboratory information regarding infants screened and cases with nonnormal results. Objectives To present data from a spectrum of SCID newborn screening programs, establish population-based incidence for SCID and other conditions with T-cell lymphopenia, and document early institution of effective treatments.ĭesign Epidemiological and retrospective observational study. The incidence of SCID is estimated at 1 in 100 000 births. Currently 23 states, the District of Columbia, and the Navajo Nation conduct population-wide newborn screening for SCID. Importance Newborn screening for severe combined immunodeficiency (SCID) using assays to detect T-cell receptor excision circles (TRECs) began in Wisconsin in 2008, and SCID was added to the national recommended uniform panel for newborn screened disorders in 2010. Richard Stiehm, MD 33 Robert W. Sugerman, MD 46 John L. Sullivan, MD 31 Susan Tanksley, PhD 30 Millard L. Tierce IV, DO 41 James Verbsky, MD, PhD 40 Beth Vogel, MS 16 Rosalyn Walker, MD 24 Kelly Walkovich, MD 21 Jolan E. Walter, MD, PhD 47,48 Richard L. Wasserman, MD, PhD 46 Michael S. Watson, MS, PhD 5 Geoffrey A. Weinberg, MD 27 Leonard B. Weiner, MD 49 Heather Wood, MS 6 Anne B. Yates, MD 24 Jennifer M. Puck, MD 1,2 Celine Hanson, MD 28,29 Beverly N. Hay, MD 31 Diana Hu, MD 32 Anthony Infante, MD, PhD 15 Daisy Johnson, BSN 30 Neena Kapoor, MD 18,19 Denise M. Kay, PhD 16 Donald B. Kohn, MD 33 Rachel Lee, PhD 30 Heather Lehman, MD 10 Zhili Lin, PhD 34 Fred Lorey, PhD 4 Aly Abdel-Mageed, MD, MBA 26 Adrienne Manning, BS 35 Sean McGhee, MD 36,37 Theodore B. Moore, MD 33 Stanley J. Naides, MD 38 Luigi D. Notarangelo, MD 12,13 Jordan S. Orange, MD 28,29 Sung-Yun Pai, MD 12,13 Matthew Porteus, MD, PhD 36,37 Ray Rodriguez, MD, JD, MPH, MBA 24 Neil Romberg, MD 39 John Routes, MD 40 Mary Ruehle, MS 41 Arye Rubenstein, MD 42 Carlos A. Saavedra-Matiz, MD 16 Ginger Scott, RN 30 Patricia M. Scott, MT 43 Elizabeth Secord, MD 41 Christine Seroogy, MD 44 William T. Shearer, MD, PhD 28,29 Subhadra Siegel, MD 45 Stacy K. Silvers, MD 46 E. Shared Decision Making and CommunicationĪntonia Kwan, PhD, MRCPCH 1,2 Roshini S. Abraham, PhD 3 Robert Currier, PhD 4 et al Amy Brower, PhD 5 Karen Andruszewski, BS 6 Jordan K. Abbott, MD 7 Mei Baker, MD 8,9 Mark Ballow, MD 10 Louis E. Bartoshesky, MD 11 Vincent R. Bonagura, MD 50 Francisco A. Bonilla, MD, PhD 12,13 Charles Brokopp, DrPH 14 Edward Brooks, MD 15 Michele Caggana, ScD 16 Jocelyn Celestin, MD 17 Joseph A. Church, MD 18,19 Anne Marie Comeau, PhD 20,31 James A. Connelly, MD 21 Morton J. Cowan, MD 1,2 Charlotte Cunningham-Rundles, MD 22 Trivikram Dasu, PhD 23 Nina Dave, MD 24 Maria T. De La Morena, MD 25 Ulrich Duffner, MD 26 Chin-To Fong, MD 27 Lisa Forbes, MD 28,29 Debra Freedenberg, MD 30 Erwin W. Gelfand, MD 7 Jaime E. Hale, BS 20 I.Scientific Discovery and the Future of Medicine.Health Care Economics, Insurance, Payment. ![]() ![]() Clinical Implications of Basic Neuroscience. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |